Pharmaceutical Industry
By Fortune EditorsMay 31, 2023
CommentaryWhy the underestimated economic burden of rare diseases could be costing the U.S. trillions of dollars
By Giacomo ChiesiMay 25, 2023
HealthA Colorado panel of medical and pharmacy experts will decide whose medicine to make affordable this summer
By Markian Hawryluk and KFF Health NewsMay 22, 2023
CommentarySanofi CEO: ‘Europe’s lead in life sciences R&D is eroding–but co-localized hubs could allow it to keep up’
By Paul HudsonMay 17, 2023
By Matthew Perrone and The Associated PressApril 25, 2023
HealthThere’s a small but very real chance that over-the-counter medication could send you to the emergency room, says team that studies medications
By Macarius Mwinisungee Donneyong, Ximena Oyarzún-González and The ConversationApril 21, 2023
HealthHow Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
By Arthur Allen and KFF Health NewsApril 13, 2023
NewslettersU.S. women need better birth control. So why is this contraceptive company ‘on life support?’
By Maria Aspan and Kinsey CrowleyApril 5, 2023
HealthA 79-year-old ‘white collar drug dealer’ who sold opioids to pharmacies is going to serve only 2 years in prison
By Bob Van Voris and BloombergMarch 8, 2023
By Helen Santoro and Kaiser Health NewsFebruary 27, 2023
By Darius Tahir and Kaiser Health NewsFebruary 17, 2023
HealthThe first drug to have even a limited impact on Alzheimer’s just got FDA approval. ‘This drug is not a cure.’
By Matthew Perrone and The Associated PressJanuary 6, 2023
Most Popular
